Inventor · disambiguated record
Sharon Cunningham
Also filed as: CUNNINGHAM SHARON
3 granted patents·3 pending applications·2 citations·filing 2015–2024
53Inventor score
Files withSHORLA PHARMA LTD3CHILDRENS MEDICAL RES INSTITUTE1THE SYDNEY CHILDRENS HOSPITALS NETWORK RANDWICK AND WESTMEAD INCORPORATING THE ROYAL ALEXANDRA HOSPI1The Sydney Children's Hospitals Network (Randwick and Westmead)(Incorporating the Royal Alexandra1
Top patents by PatentIndex Score
6 records- 0177US11351272B2Stable gene transfer to proliferating cellsTHE SYDNEY CHILDRENS HOSPITALS NETWORK RANDWICK AND WESTMEAD INCORPORATING THE ROYAL ALEXANDRA HOSPI·Filed 2019·Granted Jun 7, 2022·2 cites·9 claims
- 0261US11975013B2Stable formulations comprising thiotepaSHORLA PHARMA LTD·Filed 2022·Granted May 7, 2024·0 cites·13 claims
- 0356US2023041156A1Stable formulations comprising thiotepaSHORLA PHARMA LTD·Filed 2022·Application pending·0 cites
- 0454US2025017918A1Oral suspensions comprising temozolomide or lenalidomideSHORLA PHARMA LTD·Filed 2024·Application pending·0 cites
- 0552US11938197B2Polynucleotides and vectors for the expression of transgenesCHILDRENS MEDICAL RES INSTITUTE·Filed 2018·Granted Mar 26, 2024·0 cites·7 claims
- 0641US2017216456A1Stable Gene Transfer to Proliferating CellsThe Sydney Children's Hospitals Network (Randwick and Westmead)(Incorporating the Royal Alexandra·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sharon Cunningham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →